Frequently Asked Questions

Yes.  In Vitro Validation (2002) Led by Professor Roger Smith et al. at the Royal Veterinary College and published in the Equine Veterinary Journal. This peer-reviewed study evaluated the effectiveness of the  EqueStride™ support device against conventional fetlock support methods, including exercise boots and traditional support bandaging such as a Robert Jones. The results confirmed that EqueStride™ is the only tendon and ligament support system shown to significantly reduce strain on the tendons and suspensory ligament during exercise.   EVJ Paper 2002: https://pubmed.ncbi.nlm.nih.gov/12455845/ * *(The EqueStride™ Support System was previously known as the Dalmar tendon support.) In Vivo Validation (2025) Published by Pagliara and Cantatore et al. from the University of Turin in collaboration with Pool House Equine Clinic, UK. Twelve healthy horses were assessed, and their joint motion was quantified using sensor-based measurement during walk and trot with and without EqueStride™, confirming that EqueStride™ reduced fetlock hyperextension and tendon strain during exercise “Animals” Paper 2025: https://www.mdpi.com/2076-2615/15/13/1965

The EqueStride™ device and associated treatment methods were invented and developed by Irish industrial designer Andrew Daly BDes MA RCA IC. Daly created the EqueStride™ system to address the absence of effective tendon support methods within equine veterinary practice. His invention overcame traditional problems associated with conventional tendon and ligament injury treatment, which involves prolonged stable rest and high re-injury rates due to unsafe loading. The early introduction of safe exercise post-injury has transformed equine soft tissue rehabilitation. The first commercial design was launched in 2010, with patents filed in 2002 and with further patents filed by EqueStride™ in 2023 and 2025.

Yes, the EqueStride™ Tendon Support System is the only available dynamic support system (DSS) that has been scientifically validated to support tendon rehabilitation. EqueStride™ holds all the Intellectual Property Rights, including patent portfolio and copyrights.  The Intellectual Property Rights have not been sold, authorised or transferred by EqueStride™ to any other company or brand name. All available published papers and unpublished studies were conducted using the EqueStride™ device.